Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference390 articles.
1. Hormonal palliation of chemoresistant ovarian cancer: Three consecutive phase II trials of the Mid-Atlantic Oncology Program;Ahlgren;Journal of Clinical Oncology,1993
2. Genetic screen identifies insulin-like growth factor binding protein 5 as a Modulator of tamoxifen resistance in breast cancer;Ahn;Cancer Research,2010
3. Role of exogenous and endogenous hormones in endometrial cancer: Review of the evidence and research perspectives;Akhmedkhanov;Ann N Y Acad Sci,2001
4. Evidence for the metabolic activation of non-steroidal antioestrogens: A study of structure-activity relationships;Allen;British Journal of Pharmacology,1980
5. Estrogen receptor mutations and their role in breast cancer progression;Alluri;Breast Cancer Research,2014
Cited by 329 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. OBHSA, a novel selective estrogen receptor degrader, overcomes tamoxifen resistance through cell cycle arrest and unfolded protein response-mediated apoptosis in breast cancer;The Journal of Steroid Biochemistry and Molecular Biology;2024-11
2. Graphene oxide nanoribbons conjugated with 1, 2-distearoyl-sn-glycero-3 phosphoethanolamine-poly (ethylene glycol)-transferrin enhanced targeted delivery and cytotoxicity of raloxifene against breast cancer;International Journal of Biological Macromolecules;2024-10
3. Diarylpropionitrile-stimulated ERβ nuclear accumulation promotes MyoD-induced muscle regeneration in mdx mice by interacting with FOXO3A;Pharmacological Research;2024-10
4. Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses;Journal of Virology;2024-09-13
5. Discovery of novel quinoline scaffold selective estrogen receptor degraders (SERDs) for treatment of ER positive breast cancer with enhanced antiproliferative bioactivity through immunogenic cell death (ICD) effects;European Journal of Medicinal Chemistry;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3